Literature DB >> 19281753

Successful treatment with voriconazole of prolonged Paecilomyces lilacinus fungemia in a chronic hemodialyzed patient.

L Labriola1, B V, D Swinne, M Jadoul.   

Abstract

Paecilomyces lilacinus is a saprophytic mould which rarely causes infection in humans. We report a case of Paecilomyces lilacinus catheter-related fungemia in a chronic hemodialyzed patient. Blood cultures remained positive for 8 weeks. The infection was cured after eventual acceptance by the patient of oral voriconazole treatment for 6 weeks and removal of the tunneled catheter. The literature on Paecilomyces fungemia in humans is reviewed.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19281753     DOI： 10.5414/cnp71355

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN： 0301-0430            Impact factor:   0.975


  4 in total

1.  Paecilomyces as a Cause of Lymph Nodes Enlargement in Hodgkin's Lymphoma.

Authors:  Priya Tiwari; Nandini Hazarika; Sunita Ahlawat; Ishita B Sen; Nikhil Shirshi
Journal:  Indian J Pediatr       Date:  2017-06-29       Impact factor: 1.967

2.  Paecilomyces variotii Fungemia in a Patient with Lymphoma Needing Liver Transplant.

Authors:  A P Bellanger; J P Cervoni; J F Faucher; D Weil-Verhoeven; M Ginet; E Deconinck; F Grenouillet
Journal:  Mycopathologia       Date:  2017-04-01       Impact factor: 2.574

3.  Purpureocillium lilacinum as a cause of cavitary pulmonary disease: a new clinical presentation and observations on atypical morphologic characteristics of the isolate.

Authors:  Ziauddin Khan; Suhail Ahmad; Fahad Al-Ghimlas; Sana Al-Mutairi; Leena Joseph; Rachel Chandy; Deanna A Sutton; Josep Guarro
Journal:  J Clin Microbiol       Date:  2012-02-08       Impact factor: 5.948

4.  Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature.

Authors:  Rosanne Sprute; Jon Salmanton-García; Ertan Sal; Xhorxha Malaj; Zdeněk Ráčil; Carlos Ruiz de Alegría Puig; Iker Falces-Romero; Aleksandra Barać; Guillaume Desoubeaux; Anupma Jyoti Kindo; Arthur J Morris; René Pelletier; Joerg Steinmann; George R Thompson; Oliver A Cornely; Danila Seidel; Jannik Stemler
Journal:  J Antimicrob Chemother       Date:  2021-05-12       Impact factor: 5.790
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.